Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team
20 November 2009 - 5:00AM
PR Newswire (US)
PRINCETON, N.J., Nov. 19 /PRNewswire/ -- Impliant, Inc., a
developer of novel motion-sparing alternatives to traditional
spinal fusion surgery, announced today that it has added Noel Rolon
to its executive management team as the Vice President of Clinical
and Regulatory Affairs. (Logo:
http://www.newscom.com/cgi-bin/prnh/20080527/NETU060LOGO ) Mr.
Rolon brings 30 years of clinical and regulatory experience in the
spinal and medical device field to Impliant, including the
successful completion of several IDE/PMA studies. Most recently, he
served as Vice President of Worldwide Clinical and Regulatory
Affairs for Gentis, Inc., a developer of biomaterials-based nucleus
augmentation products for the treatment of early-stage spinal
degeneration. Prior to Gentis, Mr. Rolon served as Director of
Global Clinical Affairs for Synthes Spine, in which he was
responsible for the management of the ProDisc-L, ProDisc-C, and
In-Space Interspinous Spacer clinical trials. Preceding his time at
Synthes, Mr. Rolon held various senior regulatory and clinical
positions at Johnson & Johnson in their Ethicon, Cordis, and
Ortho Clinical Diagnostics divisions. During his time at Johnson
& Johnson, Mr. Rolon was the recipient of several awards,
including the Distinguished Analytical Chemist Award and Ortho Vice
President's Award for his work with infectious diseases. "We are
very fortunate to have Noel as part of the Impliant executive
management team," commented Todd Potokar, President & CEO of
Impliant. "His vast experience in managing IDE studies will pay
large dividends in the execution and completion of our TOPS
clinical study and the management of other key product development
initiatives moving forward." Mr. Rolon commented on his decision to
join Impliant by stating, "Throughout my career, I've had the good
fortune to help bring several motion-sparing spinal implants to
market. However, I was attracted to the TOPS device due to its
novel design and the fact that there is a growing need for the
ability to provide stabilization while maintaining motion in
patients that would otherwise require a posterior decompression and
fusion. I am honored to help lead Impliant's flagship TOPS clinical
program and to contribute to the development of the company's
product pipeline, which will undoubtedly help thousands of people
worldwide." About the TOPS(TM) System Impliant's TOPS(TM) System, a
mobile posterior device, is designed to stabilize but not fuse the
L3-4 or L4-5 vertebral level to alleviate pain stemming from spinal
stenosis with or without degenerative facet arthrosis and
spondylolisthesis. Following a laminectomy and medial facetectomy,
the device is affixed to the spine via four pedicle screws using a
standard posterior surgical approach. Impliant believes that the
TOPS(TM) System could benefit over 500,000 patients worldwide
undergoing spinal fusion surgery each year. The TOPS(TM) System is
currently not approved for sale in the United States. About
Impliant, Inc. Impliant, Inc. is a privately-held company engaged
in the development of novel spine arthroplasty solutions for some
of the most prevalent pathologies of the spine. The company's
flagship product is the TOPS(TM) System, which has the longest
clinical history in the Total Posterior Arthroplasty market
segment, dating to January 2005. Impliant is also developing the
VersaLink Fixation System, the TOPS-SP System, and several other
next-generation and multi-level technologies to further increase
its addressable market. Impliant is headquartered in Princeton, NJ
with research facilities located in Ramat Poleg, Israel.
Shareholders include Elron Electronic Industries Ltd. (Nasdaq &
TASE: ELRN). For more information about Impliant, please visit
http://www.impliant.com/.
http://www.newscom.com/cgi-bin/prnh/20080527/NETU060LOGO
http://photoarchive.ap.org/ DATASOURCE: Impliant, Inc. CONTACT:
Todd Potokar, President & CEO, , or Ronnie Levy, COO &
General Manager, , both of Impliant, Inc., +1-609-779-6800 Web
Site: http://www.impliant.com/
Copyright